Corporate Profile

Corporate Overview

Company name Taiko Pharmaceutical Co., Ltd.
Establishment date November 18, 1946
Capital JPY 1,201 million (as of the end of December 2022)
Scope of businesses
【Pharmaceutical business】
Manufacturing and sales of OTC medicines (SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet), and designated quasi-drugs (RAPPA INTESTINAL REGULATOR BF)

【Infection control business】
Manufacturing and sales of sanitation control products (including Cleverin, Cleverin LED and Cleverin Generator LISPASS)

【Other business】
Manufacturing and sales of wood vinegar-based products
Final accounting date December 31
Employees Consolidate base: 210 employees, Non-consolidated base: 175 employees(As of December 31, 2022)
Chairman Hitoshi Shibata
President and CEO Takashi Shibata
  • 1-4-1, Nishi-Honmachi, Nishi-ku, Osaka map
  • TEL : +81-6-4391-1110
【Production bases】
  • ・Suita Plant (Osaka) map
  • ・Kyoto Plant/R&D Center (Kyoto) map
  • ・Oguni Plant (Yamagata) map
【Sales bases】
  • ・Tokyo Office (Tokyo) map
  • ・Taiko TEC Co., Ltd. (Yamagata) map
  • ・Taiko Pharmaceutical International Co., Ltd. (Osaka)
  • ・Taiko Pharmaceutical (Asia Pacific) Co., Ltd (Hong Kong)
  • ・Taiko Environmental Technologies (Shanghai) Co., Ltd.
  • ・Taiwan Taiko Pharmaceutical Co., Ltd.
  • ・Taiko Pharmaceutical (Shenzhen) Co., Ltd.

Medical Products

Infection Control Products

Research and Development

Corporate Profile

Investor Information